Breaking News
TIF Position Statement on the Use of DEHP Plasticisers in Medical Devices
GBT Announces Plans to Seek Regulatory Approval for Oxbryta® (Voxelotor) to Treat Sickle Cell Patients in Europe
Dr Evangelia Yannaki on Gene Therapy _ Interview for Greek TV Station Mega Channel
Thalassaemia Prior and Consequent to COVID-19 Pandemic: The Perspective of Thalassaemia International Federation (TIF)
Advances in the Care & Cure of Thalassaemia: New Hopes & Challenges
IMR-687 Receives FDA Orphan Drug Designation for the Treatment of β-Τhalassaemia
European Commission Approves Reblozyl for the Treatment of Transfusion-dependent β-Thalassaemia
Gene Therapy & Thalassaemia: A TIF Survey
25th EHA Annual Virtual Congress: TIF Brings you All the Latest Developments on Thalassaemia
COVID-19 & Haemoglobin Disorders: A TIF Webinar with Patients from America
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
Search for
RSS
Instagram
YouTube
Twitter
Facebook
Home
/
Sitemap
Sitemap
Back to top button
Close
Search for
Close
Log In
Forget?
Remember me
Log In
Cookies
This site uses cookies.
Περισσότερα
Έγινε, ευχαριστώ
